NAD Supplement for Parkinson's Disease Study
Treatments studied
Part of Brain & nervous system clinical trials.
This study tests whether a supplement called NAD (a natural substance that helps cells produce energy) can improve symptoms in people with Parkinson's disease. You would take the supplement daily for several weeks, and researchers will check your movement, thinking, and overall well-being.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have Parkinson's disease diagnosed by a movement disorder specialist, and your symptoms are mild to moderate (stages I to III on the Hoehn and Yahr scale).
- You are 55 years or older.
- You can see and hear well enough to take part in the tests (with glasses or hearing aids if needed).
- You are able to give your own consent in English and can do seated and walking tasks (with a walker or cane if needed).
- Your Parkinson's medications have not changed in the past 4 weeks, or you are not on any Parkinson's medications.
- You do not have serious health problems like active cancer, uncontrolled seizures, recent stroke, major depression not controlled on meds, or significant kidney or liver problems.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a supplement called resveratrol (found naturally in grapes and berries) can help slow or improve Parkinson's disease symptoms. You'll take resveratrol pills or a placebo while researchers monitor your memory, movement, and overall health.
This trial studies whether taking an NAD supplement can support brain blood vessel health as people age. Participants will be tested for brain and health changes and may help researchers understand how to keep the brain’s blood vessels healthier over time.
This trial tests whether a supplement called nicotinamide riboside (NR) can help people with rare forms of parkinsonism (PSP, MSA, or CBS). It is a double-blind study, meaning neither you nor the doctors will know if you are getting the real supplement or a placebo.
This trial tests if a vitamin B3-like supplement, nicotinamide riboside, can help people with early to mid-stage Huntington's disease. You will be randomly assigned to take the supplement or a placebo to see if it slows the disease.
This trial tests how well a new injectable form of Niagen (a supplement that may boost cellular energy) is absorbed and tolerated compared to NAD+. It may help if you are between 40 and 65, live near the study site, and feel unusually tired.
This study tests whether a supplement called nicotinamide riboside (a form of vitamin B3) can improve walking ability in people with peripheral artery disease (PAD), a condition that causes leg pain when walking due to poor blood flow. It is a phase 3 trial, meaning it's in the final stages of testing before possible approval.
Hear when a new Parkinson’s disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.